← All stocks

ARS Pharmaceuticals, Inc.

SPRY No buying or selling

CIK 0001671858 #3013 in the set updated 19 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

11 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Lowenthal Richard E

PRESIDENT AND CEO

—

5,523,683

$55.24M

−10.0%

Flynn James E

10% owner

—

4,887,254

$48.87M

−21.1%

Tanimoto Sarina

CHIEF MEDICAL OFFICER

—

4,680,959

$46.81M

−11.6%

Shah Pratik

Director

—

4,474,554

$44.75M

−7.3%

Shawver Laura

Director

—

210,346

$2.10M

0.0%

Fitzpatrick Alexander A

Chief Legal Officer

—

90,910

$909.10K

−6.5%

Karas Eric

Chief Commercial Officer

—

12,176

$121.76K

0.0%

Dorsey Brian

Chief Operating Officer

—

10,789

$107.89K

0.0%

Scott Kathleen D.

Chief Financial Officer

—

10,042

$100.42K

0.0%

SAUNDERS BRENT L

Director

—

$0.00

—

Chakma Justin

Chief Business Officer

—

$0.00

−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 7 Dec 2020